Welcome to the e-CCO Library!

P012 α4β7 Receptor occupancy by vedolizumab at trough time-point occurs at the membranal level and is not associated with endoscopic healing in inflammatory bowel disease patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

B. Ungar1,2, Z. Ben-Shatach1,2, O. Haj-Natour1,2, M. Yavzori1,2, E. Fudim1,2, O. Picard1,2, D. Coscas1,2, A. Lahat1,2, M. Lidar2,3, R. Eliakim1,2, U. Kopylov1,2, S. Ben-Horin1,2

Created: Thursday, 30 January 2020, 10:12 AM
P0120: Study of the Implication of the Epithelium in the Development and Progression of Fibrosis in Ulcerative Colitis
Year: 2025
Source: ECCO'25
Authors: Stepniakx7x7x7 M.(1)*;Adamx7x7x7 P.(1);Saléex7x7x7 C.(1);Massotx7x7x7 C.(1);Lolyx7x7x7 J.P.(2);Vieujeanx7x7x7 S.(1x7x7x72x7x7x73);Reenaersx7x7x7 C.(2);Coimbra Garcia Marquesx7x7x7 C.(4);Deckerx7x7x7 E.(4);Delvennex7x7x7 P.(5);Blétardx7x7x7 N.(6);Specax7x7x7 S.(7);Beqx7x7x7 S.(8);Louisx7x7x7 E.(1x7x7x72);Meuwisx7x7x7 M.A.(1x7x7x72);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0121: Molecular features of extracellular matrix activity persist in patients who achieve mucosal healing with ustekinumab induction
Year: 2025
Source: ECCO'25
Authors: Saifuddinx7x7x7 A.(1)*;Cozzettox7x7x7 D.(2);Powellx7x7x7 N.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0122: The Potential Role of Circulating Cytokines and Chemokines To Predict Intestinal Failure in Patients Affected by Short Bowel Syndrome
Year: 2025
Source: ECCO'25
Authors: Di Mattiax7x7x7 M.(1)*;Panex7x7x7 C.(1);Petitox7x7x7 V.(2);Profeta x7x7x7 F.(2);Foscarinix7x7x7 E.(2);Lamolinarax7x7x7 A.(3);Iezzix7x7x7 M.(3);Troisix7x7x7 S.(1x7x7x72);Masix7x7x7 L.(2);Emolix7x7x7 V.(2);Becheruccix7x7x7 G.(2);Turchinix7x7x7 L.(2);Gasbarrinix7x7x7 A.(2x7x7x74x7x7x75);Papax7x7x7 A.(4x7x7x75);Scaldaferri x7x7x7 F.(2x7x7x74x7x7x75);Lopetusox7x7x7 L.R.(1x7x7x72);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0123: The immune system of patients with immune-mediated diseases perceives dysbiotic intestinal microbial speciesx7x7x7 and IgG reactivity uncovers shared and non-shared responses across diseases
Year: 2025
Source: ECCO'25
Authors: Barendregtx7x7x7 D.(1)*;Gacesax7x7x7 R.(2);Plompx7x7x7 N.(3);Caladox7x7x7 B.(1);Bourgonjex7x7x7 A.R.(2);van Heckx7x7x7 J.I.P.(4);van Mourikx7x7x7 A.G.(5);van der Woudex7x7x7 D.(5);Weersmax7x7x7 R.K.(2);Joostenx7x7x7 L.A.B.(4);Lubbertsx7x7x7 E.(6);Rizopoulosx7x7x7 D.(7);Chandlerx7x7x7 F.(8);Sikkemax7x7x7 R.S.(8);Harmsenx7x7x7 H.J.M.(3);de Ridderx7x7x7 L.(9);Samsomx7x7x7 J.N.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0124: Therapeutic Potential of Adipose-Derived Extracellular Vesicles for Inflammation Modulation and Mucosal Healing in Crohn’s Disease
Year: 2025
Source: ECCO'25
Authors: Cluax7x7x7 L.(1)*;Suaux7x7x7 R.(1);Monfort-Ferréx7x7x7 D.(2);Boronat-Toscanox7x7x7 A.(2);Menachox7x7x7 M.(2);Carox7x7x7 A.(2);Mañasx7x7x7 M.J.(3);Mañosax7x7x7 M.(4);Domènechx7x7x7 E.(4);Manyéx7x7x7 J.(5);Serenax7x7x7 C.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0125: Crohn’s-associated invariant T Cells are associated with disease severity and location and are not affected by medication intake
Year: 2025
Source: ECCO'25
Authors: Mahdyx7x7x7 A.(1)*;ElAbdx7x7x7 H.(1);Kriukovax7x7x7 V.(1);Olbjørnx7x7x7 C.(2);Perminowx7x7x7 G.(3);Bengtsonx7x7x7 M.B.(4);Ricanekx7x7x7 P.(5);Andersenx7x7x7 S.(6);Detliex7x7x7 T.(7);Kristensenx7x7x7 V.(8);Hovx7x7x7 J.(9);Høivikx7x7x7 M.(8);Frankex7x7x7 A.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0126: Single-cell analysis reveals enrichment of mucosal Th17-polarized T cells in Acute Severe Ulcerative Colitis
Year: 2025
Source: ECCO'25
Authors: Bourgonjex7x7x7 A.R.(1x7x7x72)*;Meringerx7x7x7 H.(1x7x7x72x7x7x73);Roudkox7x7x7 V.(4);Jhax7x7x7 D.(1x7x7x72);Canales-Herreriasx7x7x7 P.(1x7x7x72);Livanosx7x7x7 A.E.(1x7x7x72);Cossarinix7x7x7 F.(5);Tankelevichx7x7x7 M.(1x7x7x72);D'Souzax7x7x7 D.(4);Niex7x7x7 K.(4);Kim-Schulzex7x7x7 S.(4);Petraliax7x7x7 F.(6);Kayalx7x7x7 M.(1);Colombelx7x7x7 J.F.(1);Mehandrux7x7x7 S.(1x7x7x72);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0127: Fistula-derived fibroblasts express genes associated with a dysfunctional wound healing process
Year: 2025
Source: ECCO'25
Authors: Van Osx7x7x7 B.(1)*;Sux7x7x7 J.(1);Brucknerx7x7x7 R.(1);Zhoux7x7x7 Z.(1);van der Meulen-de Jongx7x7x7 A.(1);Hawinkelsx7x7x7 L.(1);Barnhoornx7x7x7 M.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0128: IL-27 signallingx7x7x7 but not IL-1Bx7x7x7 is functionally relevant in the pathophysiology of immune checkpoint inhibitor induced colitis
Year: 2025
Source: ECCO'25
Authors: Ibraheimx7x7x7 H.(1)*;Cozzettox7x7x7 D.(1);Goldinx7x7x7 R.(2);Kudox7x7x7 H.(2);Zhoux7x7x7 X.(1);Lox7x7x7 J.W.(1);Powellx7x7x7 N.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0129: Distinct involvement of plasma cells and monocytes/macrophages in ileal and colonic ulcer formation in patients with Crohn's disease
Year: 2025
Source: ECCO'25
Authors: PierreDr.x7x7x7 N.(1)*;Jacobsx7x7x7 N.(2);Fernández-Verdejox7x7x7 R.(3);Louisx7x7x7 E.(1);Vieujeanx7x7x7 S.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P012: Identification of ectopic olfactory receptor gene in ulcerative colitis patients and functional analysis of OR51E2 using ex vivo culture of colonic organoid in both human and mice
Year: 2018
Source: ECCO '18 Vienna
Authors:

B.J. Lee*, M.K. Joo, H.J. Kim, J.-J. Park, J.S. Kim, Y.T. Bak, J.S. Koo, Y.T. Jeen

Created: Thursday, 21 February 2019, 9:14 AM
P012: IL22 expression in intestinal immune cells is not augmented by AHR activation in health or Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Harrow*1,2, R. Datta1, A. Stagg1, J. O. Lindsay1,2

Created: Friday, 22 February 2019, 9:41 AM
P012: Low frequencies of circulating inhibitory TIGIT+CD38+ effector T cells identify an immunologically distinct subgroup of pediatric patients with severe Crohn's disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Heredia, M.(1);Costes, L.(1);Tindemans, I.(1);Aardoom, M.(2);Klomberg, R.(2);Kemos, P.(3);Joosse, M..(1);van Haaften, D.(1);Tuk, B.(1);Ruemmele, F.(4);Croft, N.(3);Escher, J.(2);de Ridder, L.(2);Samsom, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P012: MAIT cell activation reflects mucosal inflammation in ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

K. Haga*1, A. Chiba2, T. Shibuya1, T. Osada1, D. Ishikawa1, T. Kodani1, O. Nomura1, S. Watanabe1, S. Miyake2

Created: Friday, 22 February 2019, 9:49 AM
P012: Ral activation exacerbates colonic inflammation through the impairment of intestinal barrier function in experimental murine colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Minami N.*1, Matsuura M.1, Yamamoto S.1, Honzawa Y.1, Yamada S.1, Koshikawa Y.1, Okabe M.1, Seno H.1, Horiuchi H.2, Nakase H.3

Created: Wednesday, 20 February 2019, 10:36 AM
P012: The administration of mm-miR-378a-3p exacerbates chronic inflammation and fibrosis in a murine intestinal model
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Seco-Cervera, M.(1)*;Argilés-Arberola, D.(2);Bauset, C.(2);Lis-López, L.(1);Coll, S.(2);Cosín-Roger, J.(1);Ortiz-Masià, D.(2);Calatayud, S.(2);Barrachina, M.D.(2);
Created: Friday, 14 July 2023, 10:43 AM
P012: The effect of Oncostatin M on human intestinal organoids
Year: 2022
Source: ECCO'22
Authors: Filidou, E.(1);Kandilogiannakis, L.(1);Kokkotis, G.(2);Tarapatzi, G.(1);Arvanitidis, K.(1);Drygiannakis, I.(3);Valatas, V.(3);Paspaliaris, V.(4);Kolios, G.(1);Bamias, G.(2);
Created: Friday, 11 February 2022, 3:52 PM
P013 The JAK-3 and TYK-2 / STAT pathways are activated in moderate to severe ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Loza1, J.M. Brea1, C. Calviño-Suarez2, I. Baston-Rey2, R. Ferreiro-Iglesias2, J.E. Dominguez-Munoz2, M. Barreiro-de Acosta2

Created: Thursday, 30 January 2020, 10:12 AM
P0130: Assessment of macrophage types in the intestinal tissue of treatment naïve Inflammatory Bowel Disease patients in relation to their disease and activation of the CCL2/CCR2 pathway
Year: 2025
Source: ECCO'25
Authors: Begumx7x7x7 J.(1)*;Fatimax7x7x7 A.(1);Rimmerx7x7x7 P.(2);Iqbalx7x7x7 T.(3);Stoicax7x7x7 V.(2);Owusux7x7x7 M.(2);Leliosx7x7x7 I.(4);McGettrickx7x7x7 H.(5);Welfordx7x7x7 R.(4);Iqbalx7x7x7 A.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session